Cash T, Marachelian A, DuBois SG, Chi YY, Groshen SG, Shamirian A, Stout AC, Macy ME, Pinto NR, Desai AV, Sondel PM, Asgharzadeh S, Weiss BD, Mosse YP, Matthay KK, Park JR, Goldsmith KC. Phase I Study of 131I-MIBG with Dinutuximab for Patients with Relapsed or Refractory Neuroblastoma: A Report from the New Approaches to Neuroblastoma Therapy (NANT) Consortium. DOI: 10.1200/JCO.2022.40.16_suppl.10038 Journal of Clinical Oncology 40, no. 16_suppl (June 01, 2022) 10038-10038.
Cash T, Krailo MD, Buxton AB, Pawel BR, Healey JH, Binitie O, Marcus KJ, Grier HE, Grohar PJ, Reed DR, Weiss AR, Gorlick R, Janeway KA, DuBois SG, Womer RB. Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031. J Clin Oncol. 2023 Oct 20;41(30):4724-4728. doi: 10.1200/JCO.23.00053. Epub 2023 Aug 31. PMID: 37651654; PMCID: PMC10602538.
Cash T, Fox E, Liu X, Minard CG, Reid JM, Scheck AC, Weigel BJ, Wetmore C. A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515). Pediatr Blood Cancer. 2021 Sep;68(9):e29065. doi: 10.1002/pbc.29065. Epub 2021 Apr 21. PMID: 33881209; PMCID: PMC9090141.
Qayed M, Cash T, Tighiouart M, MacDonald TJ, Goldsmith KC, Tanos R, Kean L, Watkins B, Suessmuth Y, Wetmore C, Katzenstein HM. A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors. Pediatr Blood Cancer. 2020 Apr;67(4):e28134. doi: 10.1002/pbc.28134. Epub 2019 Dec 25. PMID: 31876107.
Cash T, Jonus HC, Tsvetkova M, Beumer JH, Sadanand A, Lee JY, Henry CJ, Aguilera D, Harvey RD, Goldsmith KC. A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors. Pediatr Blood Cancer. 2023 Aug;70(8):e30405. doi: 10.1002/pbc.30405. Epub 2023 May 9. PMID: 37158620.
Cash T, Aguilera D, Macy ME, Hoffman L, Dorris K, McCracken C, Hanberry B, Castellino RC, MacDonald T, and Wetmore C. Phase 1 Study of Abemaciclib in Children with Recurrent and Refractory Solid Tumors Including Malignant Brain Tumors. Molecular Cancer Therapeutics 2019;18(12 Suppl):Abstract nr C002. doi:10.1158/1535-7163.TARG-19-C002.
Cash T, Aguilera D, Ginn KF, Hoffman LM, Keesari R, Petersen WC, Caywood EH, Qayed M, Connelly E, Milla SS, Castellino RC, Fangusaro J, MacDonald TJ, Wetmore C, Katzenstein HM. A Phase 2 Study of Sirolimus in Combination with Metronomic Chemotherapy in Children with Recurrent and/or Refractory Solid and CNS Tumors. Journal of Clinical Oncology. 2023; 41:16_suppl, 10024-10024.
Metts J, Ginn K, Cost C, Froug B, Watt A, Schink M, Senn S, Cash T. A Phase I Study of Nab-Paclitaxel Combined with Gemcitabine for Pediatric Relapsed/Refractory Solid Tumors. Pediatric Blood & Cancer. 2022;69 Suppl 5:e29952. doi: 10.1002/pbc.29952.